Bioxyne Ltd (BXN) - Total Liabilities
Based on the latest financial reports, Bioxyne Ltd (BXN) has total liabilities worth AU$14.45 Million AUD (≈ $10.23 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore BXN net assets growth trend to track the company's year-over-year net asset growth rate.
Bioxyne Ltd - Total Liabilities Trend (2000–2025)
This chart illustrates how Bioxyne Ltd's total liabilities have evolved over time, based on quarterly financial data. See Bioxyne Ltd free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
Bioxyne Ltd Competitors by Total Liabilities
The table below lists competitors of Bioxyne Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Garuda Maintenance Facility AeroAsia Tbk PT
JK:GMFI
|
Indonesia | Rp658.98 Million |
|
Samick Thk
KO:004380
|
Korea | ₩257.11 Billion |
|
Titan Minerals Ltd
AU:TTM
|
Australia | AU$7.47 Million |
|
Shanghai Haixin Group Co Ltd B
SHG:900917
|
China | $813.34 Million |
|
Inseego Corp
NASDAQ:INSG
|
USA | $109.57 Million |
|
Humanica Public Company Limited
BK:HUMAN
|
Thailand | ฿553.69 Million |
|
Microbot Medical Inc
NASDAQ:MBOT
|
USA | $3.96 Million |
|
Maywood Acquisition Corp. Class A Ordinary Shares
NASDAQ:MAYA
|
USA | $4.61 Million |
Liability Composition Analysis (2000–2025)
This chart breaks down Bioxyne Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see BXN market cap overview.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.79 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.72 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.42 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Bioxyne Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Bioxyne Ltd (2000–2025)
The table below shows the annual total liabilities of Bioxyne Ltd from 2000 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-06-30 | AU$9.53 Million ≈ $6.74 Million |
+180.33% |
| 2024-06-30 | AU$3.40 Million ≈ $2.40 Million |
+26.46% |
| 2023-06-30 | AU$2.69 Million ≈ $1.90 Million |
+231.55% |
| 2022-06-30 | AU$810.43K ≈ $573.43K |
+8.82% |
| 2021-06-30 | AU$744.75K ≈ $526.96K |
+2.57% |
| 2020-06-30 | AU$726.12K ≈ $513.78K |
-12.44% |
| 2019-06-30 | AU$829.32K ≈ $586.80K |
+13.77% |
| 2018-06-30 | AU$728.93K ≈ $515.76K |
+19.57% |
| 2017-06-30 | AU$609.62K ≈ $431.34K |
+32.99% |
| 2016-06-30 | AU$458.40K ≈ $324.35K |
+99.85% |
| 2015-06-30 | AU$229.37K ≈ $162.29K |
-46.32% |
| 2014-06-30 | AU$427.26K ≈ $302.31K |
-53.20% |
| 2013-06-30 | AU$912.95K ≈ $645.97K |
-10.69% |
| 2012-06-30 | AU$1.02 Million ≈ $723.28K |
+960.49% |
| 2011-06-30 | AU$96.39K ≈ $68.20K |
-45.01% |
| 2010-06-30 | AU$175.29K ≈ $124.03K |
-60.38% |
| 2009-06-30 | AU$442.48K ≈ $313.09K |
-59.98% |
| 2008-06-30 | AU$1.11 Million ≈ $782.24K |
+182.40% |
| 2007-06-30 | AU$391.49K ≈ $277.00K |
-40.93% |
| 2006-06-30 | AU$662.74K ≈ $468.93K |
-40.52% |
| 2005-06-30 | AU$1.11 Million ≈ $788.37K |
-7.42% |
| 2004-06-30 | AU$1.20 Million ≈ $851.54K |
+18.84% |
| 2003-06-30 | AU$1.01 Million ≈ $716.55K |
+58.25% |
| 2002-06-30 | AU$639.93K ≈ $452.79K |
+18.71% |
| 2001-06-30 | AU$539.08K ≈ $381.43K |
+383.42% |
| 2000-06-30 | AU$111.51K ≈ $78.90K |
-- |
About Bioxyne Ltd
Bioxyne Limited, together with its subsidiaries, manufactures and distributes therapeutic goods, and health and wellness products in Australia, the United States, the United Kingdom, Czechia, Switzerland, France, Germany, and Japan. It operates through Pharmaceutical Manufacture and Wholesale Supply of Novel Medicines, Cannabis, Psilocybin, and MDMA; Manufacture and Distribution (Wholesale, Onlin… Read more